{
    "eid": "2-s2.0-85162871631",
    "title": "Targeting the main protease for COVID-19 treatment: A comprehensive review of computational screening and experimental studies",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [
        "antiviral drugs",
        "COVID-19",
        "drug discovery",
        "main protease (Mpro)",
        "SARS-CoV-2"
    ],
    "authors": [
        "Kamonpan Sanachai",
        "Patcharin Wilasluck",
        "Peerapon Deetanya",
        "Kittikhun Wangkanont",
        "Thanyada Rungrotmongkol",
        "Supot Hannongbua"
    ],
    "citedby-count": 0,
    "ref-count": 40,
    "ref-list": [
        "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study",
        "Running a lab amidst the COVID-19 crisis: How to stay productive during lockdowns and get ready for the New Normal",
        "Association between COVID-19 incidence and outcome and national development levels: An ecologic analysis",
        "Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges",
        "Coronavirus disease 2019: What we know?",
        "Antiviral drugs specific for coronaviruses in preclinical development",
        "Protease inhibitors targeting the main protease and papain-like protease of coronaviruses",
        "Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study",
        "Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening",
        "Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors",
        "Feline coronavirus drug inhibits the main protease of SARSCoV-2 and blocks virus replication",
        "A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication",
        "An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19",
        "Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332",
        "Paxlovid: Mechanism of action, synthesis, and in silico study",
        "Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection",
        "Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2",
        "Discovery of S-217622, a noncovalent oral SARS-CoV-2 3CL protease inhibitor clinical candidate for treating COVID-19",
        "Comprehensive fitness landscape of SARS-CoV-2 M(pro) reveals insights into viral resistance mechanisms",
        "Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation",
        "Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies",
        "Uncovering flexible active site conformations of SARS-CoV-2 3CL proteases through protease pharmacophore clusters and COVID-19 drug repurposing",
        "Identification of 14 known drugs as inhibitors of the main protease of SARS-CoV-2",
        "Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay",
        "Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbationbased virtual screening of existing drugs",
        "In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease",
        "Interaction of 8-anilinonaphthalene-1-sulfonate with SARS-CoV-2 main protease and its application as a fluorescent probe for inhibitor identification",
        "Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro",
        "Theaflavin 3-gallate inhibits the main protease (M(pro)) of SARS-CoV-2 and reduces its count in vitro",
        "Inhibitory effects of black tea theaflavin derivatives on 12-O-tetradecanoylphorbol-13-acetateinduced inflammation and arachidonic acid metabolism in mouse ears",
        "Screening for inhibitors of main protease in SARS-CoV-2: In silico and in vitro approach avoiding peptidyl secondary amides",
        "Discovery of novel inhibitors against main protease (Mpro) of SARS-CoV-2 via virtual screening and biochemical evaluation",
        "Promising SARS-CoV-2 main protease inhibitor ligand-binding modes evaluated using LB-PaCS-MD/FMO",
        "Halogenated baicalein as a promising antiviral agent toward SARS-CoV-2 main protease",
        "Semi-synthesis of N-aryl amide analogs of piperine from Piper nigrum and evaluation of their antitrypanosomal, antimalarial, and anti-SARSCoV-2 main protease activities",
        "Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease: In vitro and in silico studies",
        "N-Containing alpha-mangostin analogs via smiles rearrangement as the promising cytotoxic, antitrypanosomal, and SARS-CoV-2 main protease inhibitory agents",
        "Potent inhibitors of SARS-CoV-2 3C-like protease derived from N-substituted isatin compounds",
        "Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main protease",
        "Discovery of 4\u2032-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60017165",
            "affilname": "Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017165",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}